complications of tirzepatide Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health Tirzepatide and Semaglutide Most Efficacious

10.3389/fphar.2021.731609 162 WangY.HanY.ShangS.XiaoJ.TaoL.PengZ.et al (2024b)

If you have already achieved significant weight loss and are in a maintenance phase, you may be able to reduce your dose to a level that is more affordable at out-of-pocket prices

Your healthcare provider may wish to: Perform blood tests to exclude anaemia, thyroid dysfunction, vitamin deficiencies, electrolyte imbalances, or renal impairment Review your medication regimen for potential drug interactions or side effects from other medications Assess whether dose adjustment of Wegovy is appropriatethe titration schedule can be slowed by an additional 4 weeks or the dose temporarily reduced if side effects are problematic [1] Consider alternative causes of fatigue unrelated to Wegovy NICE guidance (TA875) emphasises the importance of ongoing monitoring during weight management interventions

PET tracers can be used to target NMDARs and AMPARs and can help facilitate both drug development and the pharmacokinetic profiling of candidate drugs [109]